# MEDTEQ+

MEDTEQ+ is an Asset Manager based in Montreal, Canada.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Montreal, Canada
- **Region:** North America
- **Address:** Montreal, Quebec, Canada
- **Founded:** 2012
- **Assets under management:** $200M–$500M (Altss estimate)
- **Website:** medteq.ca
- **LinkedIn:** https://www.linkedin.com/company/medteq-plus

## Regulatory record

- **Reports private funds:** No

## About

MEDTEQ is a nonprofit consortium founded in 2013 in Montreal, Canada. It focuses on accelerating medical technology innovation through industrial research. MEDTEQ offers programs to reduce risks associated with product development and commercialization.

## Sectors

- Digital Health
- Healthcare Services
- AI/ML
- Medical Devices

## Offices

- Halifax, Nova Scotia, Canada

## People

- Alain Beaudoin — President and CEO

## Questions

### Who runs investment decisions at MEDTEQ+?

Investment and partnership decisions are led by President and CEO Alain Beaudoin, who has headed the organization since its 2012 launch. The firm operates through a structured committee process that includes representatives from its government and private-sector funding partners, reflecting its public-private governance model.

### How does MEDTEQ+ source proprietary deal flow?

MEDTEQ+ sources opportunities through its network of university-affiliated research hospitals, provincial health authorities, and industry partners who co-sponsor clinical validation projects. This embedded relationship with the healthcare delivery system gives the firm early visibility into technologies emerging from Canadian academic medical centers.

### Does MEDTEQ+ participate in fund commitments or only direct deals?

MEDTEQ+ executes direct investments in health-tech companies through a combination of equity positions, repayable contributions, and non-repayable R&D co-financing. The firm does not operate as a fund-of-funds; its capital is deployed directly into operating companies alongside clinical validation support.

### What investment stages does MEDTEQ+ typically target?

The firm focuses on pre-seed through Series A stages, emphasizing the translational gap between academic research and commercial viability. Its model is built around de-risking technologies through clinical validation before they require larger institutional venture rounds.

### Which sectors does MEDTEQ+ explicitly avoid?

MEDTEQ+ is exclusively focused on health technology, medical devices, and digital health; it does not invest in biotech or pharmaceutical drug development, pure health-services companies without a technology component, or sectors outside healthcare.

### How is MEDTEQ+ funded, and where does the underlying capital come from?

MEDTEQ+ is funded through a consortium model combining federal government programs including the Strategic Innovation Fund, provincial economic development agencies, and more than 100 private-sector industrial partners such as hospital networks and pharmaceutical firms, per the firm's official communications. It does not represent a single family's wealth.

### Does MEDTEQ+ maintain a presence outside Quebec?

Yes, MEDTEQ+ operates dual hubs in Montreal, Quebec, and Halifax, Nova Scotia, reflecting a deliberate mandate to serve both central-Canadian and Atlantic Canadian health-technology clusters. Its investments span Ontario, Quebec, and the Atlantic provinces.

## Related profiles

- [The Right Place](https://altss.com/profile/the-right-place)
- [Blue Cross of Idaho](https://altss.com/profile/blue-cross-of-idaho)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/medteq

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology